Neonatal 6-hydroxydopamine treatment affects GABA(A) receptor subunit expression in the frontal cortex but not the hippocampus of rats during postnatal development

Developmental Neuroscience

Volumn 22, Issue 4, 2000, Pages 296-302

  Podkletnova, I ^a   Makela R ^a   Korpi, E R ^b   Luddens H ^e   Helen, P ^c   Alho, H ^d  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e NONE

Author keywords

6 Hydroxydopamine; Development; Frontal cortex; GABA(A) receptor subunits; Hippocampus; Plasticity; Rat

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; OXIDOPAMINE; PICROTOXININ; RECEPTOR SUBUNIT;

ARTICLE; BINDING SITE; CELL MATURATION; CONTROLLED STUDY; FRONTAL CORTEX; GABAERGIC TRANSMISSION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; NERVE CELL PLASTICITY; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN;

EID: 0343878782     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017453     Document Type: Article

References (27)

1. A receptor subtypes during postnatal development: An immunohistochemical study. J Neurosci 1994; 9:5302-5324.
2. A receptor alpha 1, beta 2, and gamma 2 subunit mRNAs in the granular and agranular frontal cortex of the rat during pre- and postnatal development. Cereb Cortex 1995;5:234-246.
3. A receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development. J Neurosci 1992;12:4151-4172.
4. Mäkelä R, Uusi-Oukari M, Homanics GE, Quinlan J, Fairstone L, Wisden W, Korpi E: Cerebellar γ-aminobutyric acid type A receptors: Pharmacological subtypes revealed by mutant mouse lines. Mol Pharmacol 1997;52: 380-388.
5. Lauder JM: Roles for neurotransmitters in development: Possible interaction with drugs during the fetal and neonatal periods; in Prevention of Physical and Mental Congenital Defect. New York, Liss, 1985, pp 375-380.
6. Rowe SJ, Messenger NJ, Warner AE: The role of noradrenaline in the differentiation of amphibian embryonic neurons. Development 1993;119:1343-1357.
7. Whitaker-Azmitia PM: Role of serotonin and other neurotransmitter receptors in brain development: Basis for developmental pharmacology. Pharmacol Rev 1991;43:553-561.
8. Gustafson EL, Moore RY: Noradrenaline neuron plasticity in developing rat brain: Effects of neonatal 6-hydroxydopamine demonstrated by dopamine-β-hydroxylase immunocytochemistry. Dev Brain Res 1987;37:143-155.
9. Kobayashi K, Morita S, Sawada H, Mizuguchi T, Yamada K, Nagatsu I, Hata T, Watanabe Y, Fujita K, Nagatsu T: Targeted disruption of the tyrosine hydroxylase locus results in severe catecholamine depletion and perinatal lethality in mice. J Biol Chem 1995;270:27235-27243.
10. Sachs C, Jonsson G: Effects of 6-hydroxydopamine on central noradrenaline neurons during ontogeny. Brain Res 1975;99:277-291.
11. Felten DL, Hallman H, Jonsson G: Evidence for a neurotropic role of noradrenaline neurons in the postnatal development of rat cerebral cortex. J Neurocytol 1982;11:119-135.
12. Podkletnova I, Raevsky V, Alho H: Reduction of GABAergic transmission and alterations in behavior after 6-OHDA treatment of rats. Dev Brain Res 1996;94:197-204.
13. Podkletnova I, Alho H: Neonatal noradrenaline depletion prevents the transition of Bergmann glia in the developing cerebellum. J Chem Neuroanat 1998;14:167-173.
14. A receptor subtypes in developing hippocampal neurons. Neuron 1991;7:927-936.
15. A receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci 1992;12:1040-1082.
16. 3H]Ro 15-4513 binding sites. Neuroscience 1993;53:483-488.
17. Hartmann D, Frotscher M, Sievers J: Development of granule cells, and afferent and efferent connections of the dentate gyrus after experimentally induced reorganization of the supra-and infrapyramidal blades. Acta Anat 1994; 150:25-37.
18. Schlessinger AR, Cowan WM, Gottlieb DI: An autoradiographic study of the time of origin and the pattern of granule cell migration in the dentate gyrus of the rat. J Comp Neurol 1975; 159:149-175.
19. Seidler FJ, Temple SW, McCook EC, Slotkin TA: Cocaine inhibits central noradrenergic and dopaminergic activity during the critical developmental period in which catecholamines influence cell development. Dev Brain Res 1995; 85:48-53.
20. Jacobson M: Developmental Neurobiology. New York. Plenum Press, 1978.
21. Lowell KL: Effects of 6-Hydroxydopamine-induced norepinephrine depletion on cerebellar development. Dev Neurosci 1982;5:359-368.
22. Molina-Holgado E, Dewar KM, Grondin L, van Gelder NM, Reader TA: Amino acid levels and γ-aminobutyric acid A receptors in rat neostriatum, cortex, and thalamus after neonatal 6-hydroxydopamine lesion. J Neurochem 1993;60:936-945.
23. 14C-2-deoxyglucose uptake revealed by exposure to novel stimulation. Dev Psychobiol 1992;25:183-198.
24. Hartmann D, Sievers J, Pehelemann W, Berry M: Destruction of meningeal cells over the medial cerebral hemisphere of newborn hamsters prevents the formation of the infrapyramidal blade of the dentate gyrus. J Comp Neurol 1992;320:33-61.
25. van den Buuse M, Versteeq DH, de Jong W: Brain noradrenaline and the development of hypertension: The effect of treatment with central 6-hydroxy-dopamine or DSP-4. Clin Exp Pharmacol Physiol 1986;13:469-476.
26. Super H, Martinez A, Soriano E: Degeneration of Cajal-Retzius cells in the developing cerebral cortex of the mouse after ablation of meningeal cells by 6-hydroxydopamine. Dev Brain Res 1997;98:15-20.
27. A receptor stimulation. J Neurochem 1997;68:631-639.